Literature DB >> 6138934

beta-Adrenoceptor blockade and exercise: effects on endurance and physical training.

A Juhlin-Dannfelt.   

Abstract

beta-adrenoceptor antagonists influence almost all haemodynamic and metabolic actions in the body. High levels of sympathetic stimulation accompany aerobic exercise and it is known that beta-blockade results in a decreased working capacity. Furthermore it has also been questioned whether beta-blockade inhibits the normal response to physical training. Although adrenergic mechanisms are involved in muscle and liver glycogen breakdown, beta-blockade does not seem to reduce glycogen utilisation during exercise. Both selective and non-selective beta-blockade inhibit lipolysis and result in less free fatty acids being available for muscle utilisation. Surgical and chemical sympathectomy in animals has been shown to inhibit the responses to physical training but results are now available showing that beta-adrenergic blockade does not prevent the effect of physical conditioning in patients treated with propranolol. It is concluded that beta-blockade during prolonged exercise a) does not reduce oxygen uptake by the working muscles b) decreases fat metabolism, which secondarily increases the use of carbohydrates, resulting in earlier hypoglycaemia and/or depletion of muscle glycogen with reduction in working capacity c) does not inhibit central and peripheral adaptation to physical conditioning.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6138934     DOI: 10.1111/j.0954-6820.1983.tb01613.x

Source DB:  PubMed          Journal:  Acta Med Scand Suppl        ISSN: 0365-463X


  11 in total

1.  Performance-Enhancing Drugs: Where Should the Line be Drawn and by Whom?

Authors:  Michael T Lardon
Journal:  Psychiatry (Edgmont)       Date:  2008-07

2.  Oxygen Costs of the Incremental Shuttle Walk Test in Cardiac Rehabilitation Participants: An Historical and Contemporary Analysis.

Authors:  John P Buckley; Fernando M F Cardoso; Stefan T Birkett; Gavin R H Sandercock
Journal:  Sports Med       Date:  2016-12       Impact factor: 11.136

3.  Skeletal muscle adaptation to physical training and beta-adrenergic blockade in spontaneously hypertensive rats.

Authors:  R J Favier; F Ghaemmaghami; B Sempore; D Desplanches; M H Mayet; J Frutoso; C Gharib; R Flandrois
Journal:  Eur J Appl Physiol Occup Physiol       Date:  1989

4.  The effect of verapamil on cardiovascular and metabolic responses to exercise.

Authors:  H Petri; B G Arends; M A van Baak
Journal:  Eur J Appl Physiol Occup Physiol       Date:  1986

5.  Twenty-four hour effects of oxprenolol Oros and atenolol on heart rate, blood pressure, exercise tolerance and perceived exertion.

Authors:  M A van Baak; F T Verstappen; B Oosterhuis
Journal:  Eur J Clin Pharmacol       Date:  1986       Impact factor: 2.953

6.  Effects of selective beta 2-adrenoceptor blockade on serum potassium and exercise performance in normal men.

Authors:  L Gullestad; K Birkeland; G Nordby; S Larsen; J Kjekshus
Journal:  Br J Clin Pharmacol       Date:  1991-08       Impact factor: 4.335

7.  Functional capacity in healthy volunteers before and following beta-blockade with controlled-release metoprolol.

Authors:  P K Rønnevik; J E Nordrehaug; G von der Lippe
Journal:  Eur J Clin Pharmacol       Date:  1995       Impact factor: 2.953

8.  Beta-blockade and lipolysis during endurance exercise.

Authors:  J A Wijnen; M A van Baak; C de Haan; H A Boudier; F S Tan; L M Van Bortel
Journal:  Eur J Clin Pharmacol       Date:  1993       Impact factor: 2.953

9.  Glucoregulation during exercise: hypoglycemia is prevented by redundant glucoregulatory systems, sympathochromaffin activation, and changes in islet hormone secretion.

Authors:  D R Hoelzer; G P Dalsky; W E Clutter; S D Shah; J O Holloszy; P E Cryer
Journal:  J Clin Invest       Date:  1986-01       Impact factor: 14.808

10.  Exercise capacity, energy metabolism, and beta-adrenoceptor blockade. Comparison between a beta 1-selective and a non-selective beta blocker.

Authors:  F T Verstappen; M A van Baak
Journal:  Eur J Appl Physiol Occup Physiol       Date:  1987
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.